Cowen & Co. analyst Steven Mah upgrades Absci (NASDAQ:ABSI) from Market Perform to Outperform.
Mizuho Maintains Buy on Tenet Healthcare, Lowers Price Target to $63
Mizuho analyst Ann Hynes maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $103 to $63.